The Role of DNA Damage in the Bioreductive Action of 2-Nitroimidazoles
- 1 January 1990
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Enhancement of DNA damage in mammalian cells upon bioreduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131Biochemical Pharmacology, 1988
- Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131Biochemical Pharmacology, 1987
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069British Journal of Cancer, 1986
- Interaction of the aziridine moiety of RSU-1069 with nucleotides and inorganic phosphateBiochemical Pharmacology, 1986
- RSU 1069, a nitroimidazole containing an aziridine groupBiochemical Pharmacology, 1986
- Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin CAdvances in Enzyme Regulation, 1985
- Induction of DNA strand breaks by RSU-1069, a nitroimidazole-aziridine radiosensitizerBiochemical Pharmacology, 1985
- RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977